FINZALA Trademark

Trademark Overview

On Wednesday, September 9, 2020, a trademark application was filed for FINZALA with the United States Patent and Trademark Office. The USPTO has given the FINZALA trademark a serial number of 90167486. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by Teva Women's Health, LLC. The FINZALA trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain
finzala

General Information

Serial Number90167486
Word MarkFINZALA
Filing DateWednesday, September 9, 2020
Status700 - REGISTERED
Status DateTuesday, July 30, 2024
Registration Number7463748
Registration DateTuesday, July 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain
Translation of Words in MarkThe wording "FINZALA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2020
Primary Code005
First Use Anywhere DateThursday, August 4, 2022
First Use In Commerce DateThursday, August 4, 2022

Trademark Owner History

Party NameTeva Women's Health, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameTeva Women's Health, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameTeva Women's Health, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCincinnati, OH 45213

Trademark Events

Event DateEvent Description
Saturday, September 12, 2020NEW APPLICATION ENTERED
Thursday, October 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Wednesday, January 20, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 20, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, January 20, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 20, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, January 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 13, 2021SOU EXTENSION 1 FILED
Wednesday, October 13, 2021SOU EXTENSION 1 GRANTED
Friday, October 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 19, 2022SOU EXTENSION 2 FILED
Tuesday, April 19, 2022SOU EXTENSION 2 GRANTED
Thursday, April 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 11, 2022SOU EXTENSION 3 FILED
Tuesday, October 11, 2022SOU EXTENSION 3 GRANTED
Thursday, October 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 20, 2023SOU EXTENSION 4 FILED
Thursday, April 20, 2023SOU EXTENSION 4 GRANTED
Saturday, April 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 5 FILED
Monday, October 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 23, 2023SOU EXTENSION 5 GRANTED
Tuesday, October 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024USE AMENDMENT FILED
Thursday, April 18, 2024TEAS STATEMENT OF USE RECEIVED
Monday, April 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, April 26, 2024NON-FINAL ACTION E-MAILED
Friday, April 26, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, April 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2024ASSIGNED TO LIE
Tuesday, July 30, 2024REGISTERED-PRINCIPAL REGISTER
Friday, June 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 21, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

finzala preparations diseases contraceptive pharmaceutical intravaginal treatment pregnancy neurological transdermal pain